Goiter Diffuse Toxic

Goiter Diffuse Toxic: Understanding, Symptoms and Treatment

Diffuse toxic goiter, also known as Graves' disease, Graves' disease or diffuse thyrotoxic goiter, is one of the most common endocrine diseases. It is characterized by excess secretion of thyroid hormones, resulting in hyperthyroidism, or an overactive thyroid gland. This condition can have a serious impact on the patient's overall health and quality of life.

Symptoms of diffuse toxic goiter can vary and include:

1. Rapid heartbeat and arrhythmia
2. Increased nervousness, anxiety and irritability
3. Increased sweating and warmth
4. Losing weight while maintaining appetite
5. Enlarged thyroid gland causing visible protrusion of the eyes (exophthalmos)

Diffuse toxic goiter is usually caused by autoimmune disorders, when the body's immune system begins to attack its own tissues. In this case, antibodies called TSN antibodies (thyroid stimulating immunoglobulins) stimulate the thyroid gland to release excess hormones.

The diagnosis of diffuse toxic goiter is usually based on clinical symptoms, analysis of thyroid hormone levels (such as thyroid hormones T3 and T4) and the results of an ultrasound examination of the thyroid gland. To clarify the diagnosis, a fundus examination and radioactive iodine may be required.

Treatment of diffuse toxic goiter may include several approaches, depending on the severity of symptoms and patient preferences. One of the most common methods is the use of antithyroid drugs, which reduce the activity of the thyroid gland and the level of thyroid hormones. Another option is radioactive iodine, which destroys excess thyroid tissue. In some cases, surgery may be required to remove part or all of the thyroid gland.

In addition to primary treatment, patients with diffuse toxic goiter may require symptomatic measures aimed at relieving specific symptoms, such as beta blockers to control cardiac activity and decongestants to reduce inflammation of the ocular tissues in exophthalmos.

It is important to note that toxic diffuse goiter is a chronic disease, and its treatment usually requires long-term cooperation between the patient and the doctor. Regular visits to an endocrinologist and monitoring of thyroid hormone levels are necessary to monitor the condition and adjust treatment if necessary.

In addition, patients with diffuse toxic goiter are advised to follow a healthy lifestyle, including a healthy diet, moderate physical activity and adequate rest. Avoidance of stressful situations and regular use of medications also play an important role in managing this condition.

In conclusion, diffuse toxic goiter is a common endocrine disease characterized by excessive activity of the thyroid gland. Early medical attention and proper treatment can help control symptoms and improve the patient's quality of life. If you suspect diffuse toxic goiter, it is important to contact a qualified medical specialist for diagnosis and appropriate treatment.

**Diffuse toxic goiter** (DTG) is a clinical variant of diffuse toxic goiter (TTG), the clinical picture of which differs from other manifestations of goiter, is characterized by noticeable hyperplasia and hyperfunction of the parenchyma of the parathyroid glands, leading to thyrotoxicosis, severe endocrine ophthalmopathy (EO